Showing results (31-40 of 221) with videos related to
Sort By:
Pageof 23
Parkinsonism & Related Disorders|August 2, 2017
Promising rodent models in Parkinson's diseasePaola Imbriani, Giuseppe Sciamanna, Massimo Santoro, et al.Best Practice & Research. Clinical Endocrinology & Metabolism|September 16, 2017
The molecular basis for RET tyrosine-kinase inhibitors in thyroid cancerValentina De Falco, Francesca Carlomagno, Hong-Yu Li, et al.Surgical Oncology Clinics of North America|August 3, 2006
Medullary thyroid cancerY Nancy You, Vipul Lakhani, Samuel A Wells, et al.Endocrinology|August 28, 2004
Minireview: RET: normal and abnormal functionsMassimo Santoro, Rosa Marina Melillo, Francesca Carlomagno, et al.Nature Clinical Practice. Endocrinology & Metabolism|December 18, 2007
New therapeutic approaches to treat medullary thyroid carcinomaMartin Schlumberger, Francesca Carlomagno, Eric Baudin, et al.Annals of the New York Academy of Sciences|July 4, 2002
Molecular mechanisms of RET activation in human cancerMassimo Santoro, Rosa Marina Melillo, Francesca Carlomagno, et al.European Journal of Medicinal Chemistry|September 19, 2014
Identification of two novel RET kinase inhibitors through MCR-based drug discovery: design, synthesis and evaluationBrendan Frett, Marialuisa Moccia, Francesca Carlomagno, et al.Oncogene|June 26, 2002
Thyroid cell transformation requires the expression of the HMGA1 proteinsMaria Teresa Berlingieri, Giovanna M Pierantoni, Vincenzo Giancotti, et al.Genes|April 30, 2021
Association Study of SLC6A4 (5-HTTLPR) Polymorphism and Its Promoter Methylation with Rehabilitation Outcome in Patients with Subacute StrokeMassimo Santoro, Mariacristina Siotto, Marco Germanotta, et al.Biochemical and Biophysical Research Communications|June 14, 2002
Generation and characterization of novel monoclonal antibodies to the Ret receptor tyrosine kinaseGiuliana Salvatore, Satoshi Nagata, Marc Billaud, et al.Pageof 23